Meeting
2020 ASCO Virtual Scientific Program
Targeting glioblastoma with novel immunocytokines.
Authors
Patrick Roth
University Hospital Zürich, Zürich, Switzerland
Patrick Roth , Tobias Weiss , Emanuele Puca , Manuela Silginer , Teresa Hemmerle , Shila Pazahr , Andrea Bink , Dario Neri , Michael Weller
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Clinical Trial Registration Number
NCT03779230
Citation
J Clin Oncol 38: 2020 (suppl; abstr 2558)
DOI
10.1200/JCO.2020.38.15_suppl.2558
Abstract #
2558
Poster Bd #
49
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Immune characterization of urothelial bladder carcinoma integrating transurethral resection of bladder tumor (TURBT) samples and serum: A feasibility study.
First Author: Carmen Alvarez-Dominguez
First Author: Hong-jiu Dai
Poster
2014 ASCO Annual Meeting
NCI experience using yeast-brachyury vaccine (GI-6301) in patients (pts) with advanced chordoma.
First Author: Christopher Ryan Heery
Poster
2024 ASCO Gastrointestinal Cancers Symposium
PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.
First Author: Takafumi Okayama